Delivery Order SPE2DB20D1100-SPE2DB25FE0KG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,234.96 to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Xeomin 100 unit vials. The contract utilizes firm fixed pricing and is scheduled for completion by November 7, 2025. This is an unset-aside, competitively awarded delivery order, with performance occurring at the vendor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a $93,868.32 firm fixed-price delivery order for 200-unit vials of Xeomin on October 17, 2025, with an ultimate completion date of November 7, 2025. This non-competitive delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $98,923.44 to AmerisourceBergen Drug Corp for the supply of Xeomin 200 Unit Vials. This competitively awarded, firm fixed-price contract is scheduled for completion by November 19, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a continuation of the company's pharmaceutical supply services to the federal government under its existing contract vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $13,409.76 to AmerisourceBergen Drug Corp for the supply of Xeomin 200 Unit Vials, with a completion date of September 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on August 13, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order falls under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,117.48 to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Xeomin 200 Unit Vials. This firm fixed-price delivery order, with an ultimate completion date of October 16, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive, non-set-aside procurement action and is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $9,609.60 to AmerisourceBergen Drug Corp for the supply of Xeomin 50 Unit Vials. This firm fixed-price, non-set-aside contract was awarded on November 4, 2025, with an ultimate completion date of November 26, 2025. The place of performance is located in Conshohocken, Pennsylvania, the vendor's corporate headquarters. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Xeomin 100 Unit Vials, with a ceiling value of $17,664.60 and a firm fixed price contract structure. This is a non-set-aside delivery order with an ultimate completion date of December 2, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's substantial role as a...
- The Defense Logistics Agency has awarded a delivery order valued at $5,587.40 to AmerisourceBergen Drug Corp for the supply of Xeomin 100 unit vials, with performance scheduled for completion by November 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's broader relationship with DLA, leveraging the...
- AmerisourceBergen Drug Corp was awarded a delivery order on September 26, 2025, valued at $33,524.40 for the supply of Xeomin 100 unit vials to support the Defense Department's Medical Supply Chain. This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 20, 2025, and performance occurring at the vendor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency awarded a delivery order valued at $11,733.54 to AmerisourceBergen Drug Corp for the supply of Xeomin 100 Unit Vials, with a completion date of November 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor to the federal government,...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE0KGDelivery Order
The Defense Logistics Agency awarded a $33,524.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Xeomin 100 unit vials, with an ultimate completion date of October 8, 2025. This non-set-aside contract is being performed at the awardee's Conshohocken, Pennsylvania location and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen is a major pharmaceutical distributor and critical federal medical procurement vendor that serves military and veteran healthcare systems through its comprehensive supply chain capabilities. This delivery order falls within AmerisourceBergen's broader $999,999,999.00 IDC with DLA Troop Support Medical (contract SPE2DX), which runs through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs. The contract enables AmerisourceBergen to supply specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. The company's track record of competitively awarded delivery orders demonstrates its capability to meet federal medical procurement requirements efficiently and reliably.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $33.5k | 9/17/25 |